spracoval Péč, J.
Dermatovenerologická klinika JLFUK a UNM Martin
Použitá literatúra je u jednotlivých autorov a tvorcov GUIDELINES
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
P. Joly1, B. Horvath2, A. Patsatsi3, S. Uzun4, R. Bech5, S. Beissert6, R. Bergman7, P. Bernard8, L. Borradori9, M. Caproni10, F. Caux11, G. Cianchini12, M. Daneshpazhooh13, D. De14, M. Dmochovski15, K. Drenovska16, J. Ehrchen14, C. Feliciani18, M. Goebeler19, R. Groves20, C. Guenther21, S. Hofmann22, D. Ioannides23, C. Kowalewski24, R. Ludwig25, Y.L. Lim26, B. Marinovic27, A.V. Marzano28,29, J.M. Mascaró Jr.30, D. Mimouni31, D.F. Murrell32, C. Pincelli33, C.P. Squarcioni34, M. Sárdy35, J. Setterfield36, E. Sprecher37,38, S. Vassileva39, K. Wozniak40, S. Yayli41, G. Zambruno42, D. Zillikens43, M. Hertl44, E. Schmidt43
JEADV 2020;34:1900-1913 ; DOI: 10.1111/jdv. 16752
1Department of Dermatology, Rouen University Hospital and INSERM U905, Centre de référence des maladies bulleuses autoimmunes, Normandie University, Rouen, France; 2Department of Dermatology, University Medical Center Groningen, Center for Blistering Diseases, University of Groningen, Groningen, the Netherlands; 3Autoimmune Bullous Diseases Unit, 2nd Dermatology Department, Papageorgiou General Hospital, Aristotle University School of Medicine, Thessaloniki, Greece; 4Department of Dermatology, Akdeniz Univesity Faculty of Medicine, Antalya, Turkey; 5Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark; 6Department of Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany; 7Department of Dermatology, Rambam Health Care Campus and The Ruth and Bruce Rappaport, Faculty of Medicine, Haifa, Israel; 8University of Reims-Champagne-Ardenne, Reims, France; 9Department of Dermatology, University Hospital of Bern, University of Bern, Bern, Switzerland; 10Department of Health Sciences, Section of Dermatology, USL Toscana Centro, Rare Diseases Unit, European Reference Network-Skin Member, University of Florence, Italy; 11Department of Dermatology and Refferal Center for Autoimmune Bullous Diseases MALIBUL, Avicenne Hospital. AP-HP, University Paris 13, Bobigny, France; 12Department of Dermatology, Cristo Re Hospital, Rome, Italy; 13Autoimmune Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran; 14Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; 15Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland; 16Department of Dermatology, Medical University Sofia, Bulgaria; 17Department of Dermatology, University of Münster, Münster, Germany; 18Dermatology unit, Azienda ospedaliero – universitaria, Universita di Parma, Parma, Italy; 19Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany; 20St. John´s Institute of Dermatology, London, UK; 21Department of Dermatology, University Hospital, Technical University Dresden, Dresden, Germany; 22Department of Dermatology, Allery and Dermatosurgery, Helios UniversityHospital Wuppertal, University Witten, Herdecke, Germany; 231st Department of Dermatology-Venereology, Hospital of Skin and Venereal Diseases, Aristotle University Medical School, Thessaloniki, Greece; 24Department of Dermatology and Immunodermatology, Medical University of Warsaw, Warsaw, Poland; 25Department of Dermatology, University Hospital, Technical University Dresden, Dresden, Germany; 26National Skin Centre, Singapore, Singapore; 27Department of Dermatology and Venereology, University of Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia; 28Dermatology Unit, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy; 29Department of Physiopathology and Transplatation, Universita degli Studi di Milano, Milan, Italy; 30Department of Dermatology, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain; 31Department of Dermatology, Rabin Medical Center, petha-Tikwa and Sacler School of Medicine, Tel Aviv University, Tel Aviv, Israel; 32Department of Dermatology, St. George Hospital, University of NSW, Sydney, NSW, Australia; 33DermoLab, Institute of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; 34Department of Dermatology and Referral Center for Autoimmune Bullous Diseases MALIBUL, Avicenne Hospital, AP-HP, University Paris 13, Bobigny, France; 35Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary; 36Department of Oral Medicine, St. John´s Institute of Dermatology, Guy´s and St. Thomas´ NHS Foundation Trust, London, UK; 37Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 38Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 39Department of Dermatology, Medical University, Sofia, Bulgaria; 40Department of Dermatology and Immunodermatology, Medical University of Warsaw, Warsaw, Poland; 41Department of Dermatology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey; 42Genetics and Rare Diseases Research Division, Bambino Gesu Children´s Hospital, IRCCS, Rome, Italy; 43Department of Dermatology and Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany; 44Department of Dermatology, University of Marburg, Marburg, Germany
---
Stiahnuť / Pozrieť ČLÁNOK (PDF) | Stiahnuť / Pozrieť časopis (PDF)
